The CRISPR patent battle spans two continents

Isobel Finnie and Catherine Williamson, GEN Exclusives, 6 February 2017,

The CRISPR/Cas9 patent battle has been closely watched in the United States with a decision expected in the next few months. Less attention has been paid to the ongoing European patent battle.  Like in the US, both UC-Berkeley and The Broad Institute have submitted competing patent applications.  Currently the Broad Institute has received all granted patents over UC-Berkeley, however the Broad is facing challenges to these decisions.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply